These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10957907)

  • 1. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section D: chronic critical limb ischaemia.
    Eur J Vasc Endovasc Surg; 2000 Jun; 19 Suppl A():S144-243. PubMed ID: 10957907
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section C: acute limb ischaemia.
    Eur J Vasc Endovasc Surg; 2000 Jun; 19 Suppl A():S115-43. PubMed ID: 10957906
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).
    Dormandy JA; Rutherford RB
    J Vasc Surg; 2000 Jan; 31(1 Pt 2):S1-S296. PubMed ID: 10666287
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC).
    Eur J Vasc Endovasc Surg; 2000 Jun; 19 Suppl A():Si-xxviii, S1-250. PubMed ID: 10957904
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
    Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG
    Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section B: intermittent claudication.
    Eur J Vasc Endovasc Surg; 2000 Jun; 19 Suppl A():S47-114. PubMed ID: 10957905
    [No Abstract]   [Full Text] [Related]  

  • 7. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
    Norgren L; Hiatt WR; Dormandy JA; Nehler MR; Harris KA; Fowkes FG; ; Bell K; Caporusso J; Durand-Zaleski I; Komori K; Lammer J; Liapis C; Novo S; Razavi M; Robbs J; Schaper N; Shigematsu H; Sapoval M; White C; White J; Clement D; Creager M; Jaff M; Mohler E; Rutherford RB; Sheehan P; Sillesen H; Rosenfield K
    Eur J Vasc Endovasc Surg; 2007; 33 Suppl 1():S1-75. PubMed ID: 17140820
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC).
    Int Angiol; 2000 Mar; 19(1 Suppl 1):I-XXIV, 1-304. PubMed ID: 10855444
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation.
    Nizankowski R; Petriczek T; Skotnicki A; Szczeklik A
    Kardiol Pol; 2005 Oct; 63(4):351-60; discussion 361. PubMed ID: 16273471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular therapy for critical limb ischaemia.
    Akar AR; Durdu S; Acikgoz B
    J Intern Med; 2008 Sep; 264(3):288-9; author reply 290. PubMed ID: 18793334
    [No Abstract]   [Full Text] [Related]  

  • 11. Open bypass and endoluminal therapy: complementary techniques for revascularization in diabetic patients with critical limb ischaemia.
    Mills JL
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S34-9. PubMed ID: 18384110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing risk factors for atherosclerosis in critical limb ischaemia.
    Gottsäter A
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):478-83. PubMed ID: 16631394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous bone marrow stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral limb ischaemia].
    Boda Z; Veréb Z; Rajnavölgyi E
    Orv Hetil; 2006 Jun; 147(25):1155-60. PubMed ID: 16893130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical limb ischemia: will atherectomy and laser-directed therapy be the answer?
    Clair DG
    Semin Vasc Surg; 2006 Jun; 19(2):96-101. PubMed ID: 16782515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic randomized clinical trial is the best solution for management issues in critical limb ischemia.
    de Graaff JC; Ubbink DT; Tijssen JG; Legemate DA
    J Clin Epidemiol; 2004 Nov; 57(11):1111-8. PubMed ID: 15567626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progenitor cell therapy in patients with critical limb ischemia without surgical options.
    Sprengers RW; Lips DJ; Moll FL; Verhaar MC
    Ann Surg; 2008 Mar; 247(3):411-20. PubMed ID: 18376183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical staging of acute limb ischemia as the basis for choice of revascularization method: when and how to intervene.
    Rutherford RB
    Semin Vasc Surg; 2009 Mar; 22(1):5-9. PubMed ID: 19298929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding critical limb ischemia.
    Sieggreen M
    Nursing; 2008 Oct; 38(10):50-5; quiz 55-6. PubMed ID: 18813004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the endovascular treatment of intermittent claudication: rationale for changes in the TASC classification.
    White JV; Ryjewski C
    Semin Vasc Surg; 2007 Mar; 20(1):54-61. PubMed ID: 17386364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute limb ischemia: current perspectives. Introduction.
    Comerota AJ
    Semin Vasc Surg; 2009 Mar; 22(1):1-2. PubMed ID: 19298927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.